UPDATE : Monday, September 7, 2020
상단여백
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai  |  2020-08-26 17:47
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai  |  2020-08-26 17:17
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai  |  2020-08-26 16:19
라인
Virus cases rebound above 300, pushing nation closer to tightest restrictions
Korea’s new Covid-19 cases climbed back above 300 Wednesday, stepping up pr...
by Shim Hyun-tai  |  2020-08-26 13:35
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai  |  2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai  |  2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai  |  2020-08-25 14:50
라인
New virus cases below 300 for 2nd day but spreads continue
Korea saw new Covid-19 cases of below 300 for the second day on Tuesday but...
by Shim Hyun-tai  |  2020-08-25 11:51
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai  |  2020-08-24 18:02
라인
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai  |  2020-08-24 18:01
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai  |  2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai  |  2020-08-24 16:12
라인
Despite fall in new virus cases, calls rise for tightest social distancing
New virus cases dropped below 300 on Monday, but epidemiological experts ca...
by Shim Hyun-tai  |  2020-08-24 15:42
라인
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
Korea’s new virus cases exceeded 300 for two consecutive days on Saturday, ...
by Shim Hyun-tai  |  2020-08-22 19:08
라인
Seoul using near 80% of Covid-19 sickbeds
Out of the 1,118 sickbeds for the Covid-19 patients in the Seoul metro regi...
by Shim Hyun-tai  |  2020-08-21 18:10
라인
Korea going all out to import, develop Covid-19 vaccines, treatments
As global competition heats up to secure the Covid-19 vaccines, the Korean ...
by Shim Hyun-tai  |  2020-08-21 16:06
라인
Daewoong to co-develop esophagitis drug for treating Covid-19
Daewoong Pharmaceutical signed an agreement with Institut Pasteur Korea (IP...
by Shim Hyun-tai  |  2020-08-20 18:41
라인
Korea speeds up developing coronavirus-related products
The government plans to accelerate the development of Covid-19 diagnostic k...
by Shim Hyun-tai  |  2020-08-20 17:58
라인
Three-digit daily viruses for a week, raising fears about 2nd round
Korea’s daily Covid-19 cases remained at three-digit figures for the seven ...
by Shim Hyun-tai  |  2020-08-20 14:56
라인
SNUBH team finds gene mutation causing stomach cancer within families
Researchers at Seoul National University Bundang Hospital (SNUBH) have foun...
by Shim Hyun-tai  |  2020-08-19 21:10
여백
여백
여백
Back to Top